BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND MAFB, Q9Y5Q3, 9935, ENSG00000204103, MGC43127, KRML
9 results:

  • 1. Recent advances of NFATc1 in rheumatoid arthritis-related bone destruction: mechanisms and potential therapeutic targets.
    Zheng H; Liu Y; Deng Y; Li Y; Liu S; Yang Y; Qiu Y; Li B; Sheng W; Liu J; Peng C; Wang W; Yu H
    Mol Med; 2024 Feb; 30(1):20. PubMed ID: 38310228
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. mafb enhances oncogenic Notch signaling in T cell acute lymphoblastic leukemia.
    Pajcini KV; Xu L; Shao L; Petrovic J; Palasiewicz K; Ohtani Y; Bailis W; Lee C; Wertheim GB; Mani R; Muthusamy N; Li Y; Meijerink JPP; Blacklow SC; Faryabi RB; Cherry S; Pear WS
    Sci Signal; 2017 Nov; 10(505):. PubMed ID: 29138297
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DNMT3A R882 mutation is associated with elevated expression of mafb and M4/M5 immunophenotype of acute myeloid leukemia blasts.
    Yang L; Liu Y; Zhu L; Xiao M
    Leuk Lymphoma; 2015; 56(10):2914-22. PubMed ID: 25721756
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The role of microRNAs in osteoclasts and osteoporosis.
    Tang P; Xiong Q; Ge W; Zhang L
    RNA Biol; 2014; 11(11):1355-63. PubMed ID: 25692234
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of novel transcriptional regulators involved in macrophage differentiation and activation in U937 cells.
    Baek YS; Haas S; Hackstein H; Bein G; Hernandez-Santana M; Lehrach H; Sauer S; Seitz H
    BMC Immunol; 2009 Apr; 10():18. PubMed ID: 19341462
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability.
    Pise-Masison CA; Radonovich M; Dohoney K; Morris JC; O'Mahony D; Lee MJ; Trepel J; Waldmann TA; Janik JE; Brady JN
    Blood; 2009 Apr; 113(17):4016-26. PubMed ID: 19131553
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
    Mahadevan D; Spier C; Della Croce K; Miller S; George B; Riley C; Warner S; Grogan TM; Miller TP
    Mol Cancer Ther; 2005 Dec; 4(12):1867-79. PubMed ID: 16373702
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. ARK5 is transcriptionally regulated by the Large-MAF family and mediates IGF-1-induced cell invasion in multiple myeloma: ARK5 as a new molecular determinant of malignant multiple myeloma.
    Suzuki A; Iida S; Kato-Uranishi M; Tajima E; Zhan F; Hanamura I; Huang Y; Ogura T; Takahashi S; Ueda R; Barlogie B; Shaughnessy J; Esumi H
    Oncogene; 2005 Oct; 24(46):6936-44. PubMed ID: 16044163
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.